A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Clinical trial NCT01670513 · UNKNOWN

Trial details

NCT number: NCT01670513
Sponsor: Dow Pharmaceutical Sciences
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2012-06-01
Primary completion: 2013-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.